The Hydration Pharmaceuticals Company Limited (ASX:HPC) Reports FY2024 Financial Results
The Hydration Pharmaceuticals Company Limited (ASX:HPC) reports a 25.5% revenue decline in FY2024, asset divestiture, and a strategic focus on US growth.
Tag: Earnings Reports
TasFoods Ltd (ASX:TFL) Announces FY2024 Results
TasFoods Ltd (ASX:TFL) reports FY2024 results, showing improved EBITDA, cost reductions, and expansion in Pet Treats and Pyengana Dairy segments.
Ariadne Australia Limited (ASX:ARA) Reports 62.5% Revenue Growth and Declares Interim Dividend
Ariadne Australia Limited (ASX:ARA) reports a 62.5% revenue increase and declares a fully franked interim dividend.
Epsilon Healthcare (ASX:EPN) Reports 43% Revenue Growth and Significant Loss Reduction for 2023
Epsilon Healthcare (ASX:EPN) reports a 43% revenue increase and a 92% reduction in net loss for 2023, alongside entering Voluntary Administration.
Life360 (ASX:360) Reports Record Q4 and FY 2024 Results
Life360 (ASX:360) reports record Q4 and FY 2024 results with 33% revenue growth and 79.6 million active users.
Sayona Mining Limited (ASX:SYA) Releases Half-Year Financial Results
Sayona Mining Limited (ASX:SYA) reports a 3% revenue increase and significantly reduced losses in its half-year financial results, alongside leadership changes and a strategic merger.
Vysarn Limited (ASX:VYS) 1HFY25 Financial Results
Vysarn Limited (ASX:VYS) reports a 5% revenue increase and strong operational cashflow for 1HFY25, surpassing guidance and advancing growth through strategic acquisitions.
WhiteHawk Limited (ASX:WHK) Reports 2024 Financial Performance and Secures New Contracts
WhiteHawk Limited (ASX:WHK) reports a 15.6% revenue increase for 2024 and renews a $2.4M contract, demonstrating financial improvement and growth.
ECS Botanics Holdings Ltd (ASX:ECS) Reports Half-Year Financial Results
ECS Botanics Holdings Ltd (ASX:ECS) reports a $1.98m net loss and strategic expansions in export markets and product offerings.
Bubs Australia Limited (ASX:BUB) Reports 23% Revenue Growth and Returns to Profit
Bubs Australia Limited (ASX:BUB) reports a 23% revenue increase and returns to profit in its half-year financial results ending December 2024.